SEC Tracker
Get the app
MXCT · XBRL financial data

MaxCyte financial statements, every quarter

The same tables from 12 filings, lined up. Matched by XBRL tag: renamed lines keep their history.

Download Excel Download CSV
How these numbers work
  • Every number comes from the company's XBRL financial data filed with the SEC, and each one links to its filing.
  • Lines are matched by XBRL tag, so a line renamed between filings keeps its history.
  • * marks a quarter worked out from the filing totals: the 10-K year minus the first three quarters, or a year-to-date total minus the earlier one. Fourth-quarter earnings per share is fourth-quarter net income over the fourth-quarter weighted shares.
  • 0 means a filing states zero; a dash (—) means no filing states that number.
  • “year only” means the 10-K gives the full year but not the quarters needed to work out the fourth. A worked-out quarter of revenue, cost of revenue or operating cash flow more than twice the company's largest quarter of the two years before is shown this way too.
  • Gross profit is shown as the company reports it; a worked-out quarter must equal revenue less cost of revenue for that quarter, or it is a dash.
  • Operating income can be above gross profit when the company books other operating income between the two, shown on its own line.
  • Shares outstanding come from each filing's cover page, as of the date printed there.
  • Quarters are fiscal: Q2 FY27 is the second quarter of the company's fiscal 2027.

Income statement

CSV

Fiscal quarters (MXCT's year ends in late December)

In thousands of dollarsSep 30, 2023Dec 31, 2023Mar 31, 2024Jun 30, 2024Sep 30, 2024Dec 31, 2024Mar 31, 2025Jun 30, 2025Sep 30, 2025Dec 31, 2025Mar 31, 2026Jun 30, 2026
Revenue8,00515,665*11,34210,4298,1648,693*10,3908,5076,8297,300*9,6517,271
Revenue from contracts with customers4,1604,755*5,5844,9655,6126,055*5,7435,8244,6034,787*4,5014,936
Cost of goods and services sold7931,573*1,4031,4881,9282,281*1,4971,5191,5961,610*1,5691,675
Gross profit7,21114,092*9,9398,9416,2366,412*8,8936,9885,2335,690*8,0825,596
Research and development6,2645,842*6,6785,6195,3164,614*5,9036,2695,3163,335*3,8574,253
General and administrative6,8208,086*7,1037,6397,7457,206*8,5268,0806,0285,482*5,9667,258
Total operating expenses21,16422,187*22,21420,90920,28919,313*21,18821,21519,38216,916*14,26715,828
Operating income (loss)(13,953)(8,096)*(12,275)(11,968)(14,053)(12,901)*(12,295)(14,227)(14,149)(11,226)*(6,185)(10,232)
Interest income2,7012,818*2,7492,5932,4962,304*2,0341,8701,7331,630*1,4351,358
Other income (expense)2,7012,818*2,7492,5932,4962,304*2,0341,8701,7331,630*1,4351,358
Net income (loss)(11,252)(5,278)*(9,526)(9,375)(11,557)(10,597)*(10,261)(12,357)(12,416)(9,596)*(4,750)(8,874)
Earnings per share, basic USD per share(0.11)(0.05)*(0.09)(0.09)(0.11)(0.10)*(0.10)(0.12)(0.12)(0.09)*(0.04)(0.08)
Earnings per share, diluted USD per share(0.11)(0.05)*—(0.09)(0.11)(0.10)*(0.10)(0.12)(0.12)(0.09)*(0.04)(0.08)
Weighted average shares, basic thousands of shares103,450103,703*104,090104,639105,110105,548*105,950106,404106,613106,734*106,875106,823
Weighted average shares, diluted thousands of shares103,450103,703*104,090104,639105,110105,548*105,950106,404106,613106,734*106,875106,823

Balance sheet

CSV

Fiscal quarters (MXCT's year ends in late December)

In thousands of dollarsSep 30, 2023Dec 31, 2023Mar 31, 2024Jun 30, 2024Sep 30, 2024Dec 31, 2024Mar 31, 2025Jun 30, 2025Sep 30, 2025Dec 31, 2025Mar 31, 2026Jun 30, 2026
Cash and cash equivalents49,17046,50622,24937,51336,95827,88423,38515,22512,97320,06514,55715,042
Short-term investments141,070121,782135,264119,817116,874126,598114,885111,33792,75582,97992,29790,648
Accounts receivable8,1675,7785,9914,5814,5604,6825,5255,7538,3063,5034,2463,922
Inventory12,53312,22911,96011,15910,3938,9148,2747,9337,6117,5477,6317,798
Prepaid and other current assets3,4003,8993,2102,5774,1243,6063,6792,9713,0004,2754,2063,664
Total current assets214,339190,194178,674175,647172,909171,684155,748143,219124,645118,369122,937121,274
Property and equipment, net23,77223,51322,80521,72020,96719,70719,92119,40418,62017,53116,63714,897
Right-of-use asset9,56811,24111,12511,00810,88810,76611,54111,34411,13510,92010,69910,472
Goodwill——————3,9193,7483,554———
Total assets266,727268,274257,930251,496248,612239,470229,961219,750213,476202,507194,473184,672
Accounts payable4477431,6749531,8651,3582,2791,2101,2861,4011,1961,734
Total current liabilities16,64917,85513,47712,27517,62115,77512,73311,55516,10214,26710,2129,895
Lease liability, non-current15,38317,96917,81517,65017,41217,17017,54617,19916,84716,48716,11315,723
Total liabilities33,35136,10731,57130,23535,31033,21930,54929,02733,20131,01726,58725,920
Accumulated deficit(170,521)(175,798)(185,324)(194,699)(206,256)(216,853)(227,114)(239,471)(251,887)(261,483)(266,233)(275,107)
Total stockholders' equity233,377232,167226,359221,261213,302206,251199,412190,723180,275171,490167,886158,752
Total liabilities and equity266,727268,274257,930251,496248,612239,470229,961219,750213,476202,507194,473184,672
Common shares outstanding (cover page) thousands of shares103,576104,129104,544105,089105,483106,028106,319106,607106,674106,861107,122103,206

Cash flows

CSV

Fiscal quarters (MXCT's year ends in late December)

In thousands of dollarsSep 30, 2023Dec 31, 2023Mar 31, 2024Jun 30, 2024Sep 30, 2024Dec 31, 2024Mar 31, 2025Jun 30, 2025Sep 30, 2025Dec 31, 2025Mar 31, 2026Jun 30, 2026
Net income (loss)(11,252)(5,278)*(9,526)(9,375)(11,557)(10,597)*(10,261)(12,357)(12,416)(9,596)*(4,750)(8,874)
Stock-based compensation3,609*3,575*3,0153,564*3,370*3,134*3,0393,514*1,954*706*1,1411,160*
Depreciation and amortization1,0811,102*1,1111,0811,0661,057*1,0961,100*1,072*1,072*1,047978*
Net cash from operating activities(8,238)*982*(10,564)(4,834)*(4,391)*(7,821)*(14,411)(9,852)*(7,458)*(2,689)*(8,169)(4,661)*
Purchases of property and equipment720*915*804294*406*147*653584*300*231*7262*
Net cash from investing activities2,815*(4,139)*(14,396)19,385*3,608*(1,665)*9,5291,538*5,192*9,676*2,6566,566*
Net cash from financing activities37*493*703713*228*412*383154*14*105*5(1,420)*
Net change in cash(5,387)*(2,665)*(24,257)15,264*(555)*(9,074)*(4,499)(8,160)*(2,252)*7,092*(5,508)485*

Compare with peers

SIC 8731 and related industry codes, similar size. Each row is the latest quarter reported.

How peers are chosen
  • SIC 8731 and related industry codes with public float (or, where float is missing, quarterly revenue) between 0.2x and 5x the company's.
  • Each row is the latest quarter the company has reported, named in the Quarter column; when that filing is a 10-K, it is the fourth quarter, never the full year.
  • Runway shows only for companies burning cash with under $10B of public float.
  • * marks a quarter worked out from the filing totals: for a 10-Q, the year-to-date total less the earlier one.
  • A cell reading “not reported” means the filings give no figure for that quarter alone.
CompanyCash ($K)Revenue, quarter ($K)Operating cash flow, quarter ($K)Shares outstandingRunwayQuarter
Maxcyte15,0427,271(4,661)*103.2M22.7 quarters 10-QJun 30, 2026
NRC Health3,32735,3921,386*22.1M— 10-QJun 30, 2026
Absci107,865not reported(27,564)*171.6M7.3 quarters 10-QJun 30, 2026
OmniAb22,8833,99310,575*145.9M— 10-QSep 30, 2026
Neogenomics139,281209,254(8,885)*129.4M18.9 quarters 10-QSep 30, 2026
Inotiv15,180117,652(1,070)*34.9M14.2 quarters 10-QMar 31, 2026

Not investment advice. Not affiliated with the U.S. SEC.